Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, is a major cause of morbidity and ...

Generated $166.8 million in 1Q 2025 revenues, including $149.9 million in U.S. net product sales <li /> SYFOVRE® (pegcetacop ...

Discover how clove tea's compounds provide benefits from pain relief to blood sugar management that might make this aromatic ...

Generated $166.8 million in 1Q 2025 revenues, including $149.9 million in U.S. net product salesSYFOVRE® (pegcetacoplan injection) injection demand grew 4% quarter-over-quarter, with U.S. net product ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product ...

The most significant risk factors include advanced age; prolonged immobility ... surgical procedures are discussed below. The current treatment options available comprise warfarin, unfractionated ...

India has launched its first human gene therapy for hemophilia, showing progress in biotech-led healthcare innovation.

PoTS typically affects women, and Dysautonomia International reported around 80 percent of those with PoTS in the U.S. are female.

Seven days after returning from a trip to Argentina, a 21-year-old woman presented to her family physician with fever, myalgia, and a macular rash on both thighs. This constellation of symptoms raised ...

MANILA, Philippines — In the beginning of the year, there was a certain electricity in the air surrounding the local bourse. After ending 2024 higher for the first time in five years, there was ...

Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $11.7 million during the ...